Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 5,6-Dimethylbenzimidazole

5,6-Dimethylbenzimidazole

5,6-Dimethylbenzimidazole structure

5,6-Dimethylbenzimidazole 

structure
  • CAS No:

    582-60-5

  • Formula:

    C9H10N2

  • Chemical Name:

    5,6-Dimethylbenzimidazole

  • Synonyms:

    1H-Benzimidazole,5,6-dimethyl-;Benzimidazole,5,6-dimethyl-;5,6-Dimethyl-1H-benzimidazole;Dimedazol;Dimedazole;Dimesol;5,6-Dimethylbenzimidazole;Dimezol;NSC 68316

  • Categories:

    Pharmaceutical Intermediates  >  Bulk Drug Intermediates

Description

light beige powder


Solid


5,6-dimethylbenzimidazole is a dimethylbenzimidazole carrying methyl substituents at positions 5 and 6. It has a role as an Escherichia coli metabolite and a human metabolite.

5,6-Dimethylbenzimidazole Basic Attributes

146.193

146.19

209-488-1

553XI1DS20

68316

2933990090

Characteristics

28.7

2.4

Solid

1.1±0.1 g/cm3

205.5 °C

376.8°C at 760 mmHg

208.6±5.7 °C

1.645

H2O: soluble

Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

129.9 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|127.73 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|130.3 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|129.9 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|130 Ų [M-H]-

Safety Information

3

S24/25

DD8280000

Stable under normal temperatures and pressures.

P264, P270, P273, P280, P301+P312, P302+P352, P305+P351+P338, P321, P330, P332+P313, P337+P313, P362, P501

H302

|Warning|H302 (66.67%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P273, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 4 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

5,6-dimethylbenzimidazole

5,6-Dimethylbenzimidazole Use and Manufacturing

Methods of Manufacturing

General procedure: A 16 mL vial with a PTFE/silicone septum and a nitrogen-bubbler line was charged with N-benzylbenzimidazole (208.1 mg, 1.0 mmol), Pd/C (10 wt percent, dry powder, reduced) (20 mg) and THF (5 mL). The mixture was treated at rt with triethylsilane (320 µL, 2.0 mmol) and then stirred under nitrogen for 14 h at rt. The mixture was filtered through a 0.45 µM PTFE syringe filter and the filtrate was concentrated in vacuo. The residue was purified by column chromatography (0 to 10percent MeOH/ dichloromethane) to afford benzimidazole as a colorless solid (117.6 mg, 0.996 mmol 99percent). The reactions generally exhibit an induction period of 5 to 30 min as indicated by the initiation of gas release (i.e., bubbling) from the reaction mixture. The use of Pd/C on a dry matrix is imperative as wet Pd/C results in decreased yield or no reaction.General procedure: To a 10mL three-necked round bottle was charged with 1a (0.54 g, 5 mmol), imidazolium chloride (0.09 g, 0.5 mmol) and N, N-dimethylformamide 2 mL. The resulting solution was warmed to120 °C and stirred at this temperature for 6 h. When the reaction was completed, 25 mL water was added and the resulting mixture was extracted with 25 mL ethyl acetate twice. The combined organic layer was successively washed with H2O (50 mL) and then brine (50 mL), then dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel with petroleum ether and ethyl acetate or recrystallized from petroleum ether/EA to give the title products.General procedure: A mixture of 1a (1b-1n, 0.4 mmol) and PhSiH3 (98 mL, 1.6 mmol)in N, N-dimethylformamide 2a (2b-2c, 1 mL) was stirred at 120 °C for 12 h. When the reaction was completed, the resulting mixture was extracted with ethyl acetate three times. The combined organic layer was washed by NaCl aqueous solution and dried over anhydrous Na2SO4, after which the solvent was removed under reduced pressure. The residue was purified by column chromatography onsilica gel with petroleum ether and ethyl acetate (6:1-1:2) to give the corresponding product 3a (3b-3p).1-(N-(Ribityl)), 2-diamino-4, 5-dimethylbenzene 3 (200mg, 0.74mmol) was dissolved in water (100mL), and the resulting solution stirred vigorously at ambient temperature. Compressed air was continuously bubbled through the solution. After 96h, the solution was extracted with EtOAc (3×30mL), and the aqueous fraction lyophilised to furnish starting material 3 (174mg, 0.64mmol, 87percent). Combined organic extracts were washed with saturated aqueous sodium hydrogen carbonate (50mL) and brine (2×50mL), before drying over MgSO

1H-Benzimidazole, 5,6-dimethyl-: INACTIVE

Computed Properties

Molecular Weight:146.19
XLogP3:2.4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:1
Exact Mass:146.084398327
Monoisotopic Mass:146.084398327
Topological Polar Surface Area:28.7
Heavy Atom Count:11
Complexity:147
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of 5,6-Dimethylbenzimidazole

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.